Mid-Trimester Amniocentesis Fetal Loss Rate
Abstract Objective To determine the postprocedure loss rate for mid-trimester genetic amniocentesis. Outcome Reduction of benign biopsy rates. Benefits To provide better advice for women about the risks and benefits of mid-trimester genetic amniocentesis, and to ensure that women are given sufficien...
Gespeichert in:
| Veröffentlicht in: | Journal of obstetrics and gynaecology Canada 2007-07, Vol.29 (7), p.586-590 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 590 |
|---|---|
| container_issue | 7 |
| container_start_page | 586 |
| container_title | Journal of obstetrics and gynaecology Canada |
| container_volume | 29 |
| creator | Wilson, R. Douglas, MD, FRCSC Langlois, Sylvie, MD, FRCPC Johnson, Jo-Ann, MD, FRCSC Wilson, R. Douglas, MD Desilets, Valerie, MD Audibert, François, MD Gagnon, Alain, MD Johnson, Jo-Ann, MD Wyatt, Philip, MD, PhD Allen, Victoria, MD Langlois, Sylvie, MD Blight, Claire, RN Chitayat, David, MD Farrell, Sandra A., MD Nelson, Tanya, PhD Nikkel, Sarah M., MD Skidmore, David, MD |
| description | Abstract Objective To determine the postprocedure loss rate for mid-trimester genetic amniocentesis. Outcome Reduction of benign biopsy rates. Benefits To provide better advice for women about the risks and benefits of mid-trimester genetic amniocentesis, and to ensure that women are given sufficient information/counselling to make a decision about screening. Summary Statement The risk of postprocedure loss is unique to the individual and is based on multiple variables. |
| doi_str_mv | 10.1016/S1701-2163(16)32501-4 |
| format | Article |
| fullrecord | <record><control><sourceid>pubmed_elsev</sourceid><recordid>TN_cdi_pubmed_primary_17623573</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S1701216316325014</els_id><sourcerecordid>17623573</sourcerecordid><originalsourceid>FETCH-LOGICAL-e289t-e3cd9192e7d399a023e165a6b3f0e02541149e03b0899e666f69041449a8682d3</originalsourceid><addsrcrecordid>eNpdkFFLwzAUhfOguDn9CUofFanmJmnavChjOBUqgs7nkCV3kNm1o-kG-_emm_ogXLicy-Hj3EPIBdBboCDvPiCnkDKQ_ArkNWdZVOKIDP_OA3IawpLSLOe5OiEDyCXjUQzJzat36az1Kwwdtsl4VfvGYt1h8CGZYmeqpGxCSN5Nh2fkeGGqgOc_e0Q-p4-zyXNavj29TMZliqxQXYrcOgWKYe64UoYyjiAzI-d8QZGyTAAIhZTPaaEUSikXUlEBQihTyII5PiKXB-56M1-h0-sYz7Q7_Zs6Gh4OBowpth5bHazH2qLzLdpOu8ZroLrvRu-70X0JOqp9N1pEwv0_gq187a2pvnCHYdls2jq-qEEHpukB0jPi9ATBvwGXuGkw</addsrcrecordid><sourcetype>Index Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Mid-Trimester Amniocentesis Fetal Loss Rate</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><source>EZB Electronic Journals Library</source><creator>Wilson, R. Douglas, MD, FRCSC ; Langlois, Sylvie, MD, FRCPC ; Johnson, Jo-Ann, MD, FRCSC ; Wilson, R. Douglas, MD ; Desilets, Valerie, MD ; Audibert, François, MD ; Gagnon, Alain, MD ; Johnson, Jo-Ann, MD ; Wyatt, Philip, MD, PhD ; Allen, Victoria, MD ; Langlois, Sylvie, MD ; Blight, Claire, RN ; Chitayat, David, MD ; Farrell, Sandra A., MD ; Nelson, Tanya, PhD ; Nikkel, Sarah M., MD ; Skidmore, David, MD</creator><creatorcontrib>Wilson, R. Douglas, MD, FRCSC ; Langlois, Sylvie, MD, FRCPC ; Johnson, Jo-Ann, MD, FRCSC ; Wilson, R. Douglas, MD ; Desilets, Valerie, MD ; Audibert, François, MD ; Gagnon, Alain, MD ; Johnson, Jo-Ann, MD ; Wyatt, Philip, MD, PhD ; Allen, Victoria, MD ; Langlois, Sylvie, MD ; Blight, Claire, RN ; Chitayat, David, MD ; Farrell, Sandra A., MD ; Nelson, Tanya, PhD ; Nikkel, Sarah M., MD ; Skidmore, David, MD ; CCMG PRENATAL DIAGNOSIS COMMITTEE ; SOGC GENETICS COMMITTEE</creatorcontrib><description>Abstract Objective To determine the postprocedure loss rate for mid-trimester genetic amniocentesis. Outcome Reduction of benign biopsy rates. Benefits To provide better advice for women about the risks and benefits of mid-trimester genetic amniocentesis, and to ensure that women are given sufficient information/counselling to make a decision about screening. Summary Statement The risk of postprocedure loss is unique to the individual and is based on multiple variables.</description><identifier>ISSN: 1701-2163</identifier><identifier>DOI: 10.1016/S1701-2163(16)32501-4</identifier><identifier>PMID: 17623573</identifier><language>eng</language><publisher>Netherlands: Elsevier Inc</publisher><subject>Amniocentesis - adverse effects ; Female ; Fetal Death - epidemiology ; Fetal Death - etiology ; genetic amniocentesis ; Humans ; miscarriage ; Obstetrics and Gynecology ; Pregnancy ; Pregnancy Trimester, Second ; prenatal screening</subject><ispartof>Journal of obstetrics and gynaecology Canada, 2007-07, Vol.29 (7), p.586-590</ispartof><rights>Society of Obstetricians and Gynaecologists of Canada</rights><rights>2007 Society of Obstetricians and Gynaecologists of Canada</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17623573$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Wilson, R. Douglas, MD, FRCSC</creatorcontrib><creatorcontrib>Langlois, Sylvie, MD, FRCPC</creatorcontrib><creatorcontrib>Johnson, Jo-Ann, MD, FRCSC</creatorcontrib><creatorcontrib>Wilson, R. Douglas, MD</creatorcontrib><creatorcontrib>Desilets, Valerie, MD</creatorcontrib><creatorcontrib>Audibert, François, MD</creatorcontrib><creatorcontrib>Gagnon, Alain, MD</creatorcontrib><creatorcontrib>Johnson, Jo-Ann, MD</creatorcontrib><creatorcontrib>Wyatt, Philip, MD, PhD</creatorcontrib><creatorcontrib>Allen, Victoria, MD</creatorcontrib><creatorcontrib>Langlois, Sylvie, MD</creatorcontrib><creatorcontrib>Blight, Claire, RN</creatorcontrib><creatorcontrib>Chitayat, David, MD</creatorcontrib><creatorcontrib>Farrell, Sandra A., MD</creatorcontrib><creatorcontrib>Nelson, Tanya, PhD</creatorcontrib><creatorcontrib>Nikkel, Sarah M., MD</creatorcontrib><creatorcontrib>Skidmore, David, MD</creatorcontrib><creatorcontrib>CCMG PRENATAL DIAGNOSIS COMMITTEE</creatorcontrib><creatorcontrib>SOGC GENETICS COMMITTEE</creatorcontrib><title>Mid-Trimester Amniocentesis Fetal Loss Rate</title><title>Journal of obstetrics and gynaecology Canada</title><addtitle>J Obstet Gynaecol Can</addtitle><description>Abstract Objective To determine the postprocedure loss rate for mid-trimester genetic amniocentesis. Outcome Reduction of benign biopsy rates. Benefits To provide better advice for women about the risks and benefits of mid-trimester genetic amniocentesis, and to ensure that women are given sufficient information/counselling to make a decision about screening. Summary Statement The risk of postprocedure loss is unique to the individual and is based on multiple variables.</description><subject>Amniocentesis - adverse effects</subject><subject>Female</subject><subject>Fetal Death - epidemiology</subject><subject>Fetal Death - etiology</subject><subject>genetic amniocentesis</subject><subject>Humans</subject><subject>miscarriage</subject><subject>Obstetrics and Gynecology</subject><subject>Pregnancy</subject><subject>Pregnancy Trimester, Second</subject><subject>prenatal screening</subject><issn>1701-2163</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpdkFFLwzAUhfOguDn9CUofFanmJmnavChjOBUqgs7nkCV3kNm1o-kG-_emm_ogXLicy-Hj3EPIBdBboCDvPiCnkDKQ_ArkNWdZVOKIDP_OA3IawpLSLOe5OiEDyCXjUQzJzat36az1Kwwdtsl4VfvGYt1h8CGZYmeqpGxCSN5Nh2fkeGGqgOc_e0Q-p4-zyXNavj29TMZliqxQXYrcOgWKYe64UoYyjiAzI-d8QZGyTAAIhZTPaaEUSikXUlEBQihTyII5PiKXB-56M1-h0-sYz7Q7_Zs6Gh4OBowpth5bHazH2qLzLdpOu8ZroLrvRu-70X0JOqp9N1pEwv0_gq187a2pvnCHYdls2jq-qEEHpukB0jPi9ATBvwGXuGkw</recordid><startdate>20070701</startdate><enddate>20070701</enddate><creator>Wilson, R. Douglas, MD, FRCSC</creator><creator>Langlois, Sylvie, MD, FRCPC</creator><creator>Johnson, Jo-Ann, MD, FRCSC</creator><creator>Wilson, R. Douglas, MD</creator><creator>Desilets, Valerie, MD</creator><creator>Audibert, François, MD</creator><creator>Gagnon, Alain, MD</creator><creator>Johnson, Jo-Ann, MD</creator><creator>Wyatt, Philip, MD, PhD</creator><creator>Allen, Victoria, MD</creator><creator>Langlois, Sylvie, MD</creator><creator>Blight, Claire, RN</creator><creator>Chitayat, David, MD</creator><creator>Farrell, Sandra A., MD</creator><creator>Nelson, Tanya, PhD</creator><creator>Nikkel, Sarah M., MD</creator><creator>Skidmore, David, MD</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope></search><sort><creationdate>20070701</creationdate><title>Mid-Trimester Amniocentesis Fetal Loss Rate</title><author>Wilson, R. Douglas, MD, FRCSC ; Langlois, Sylvie, MD, FRCPC ; Johnson, Jo-Ann, MD, FRCSC ; Wilson, R. Douglas, MD ; Desilets, Valerie, MD ; Audibert, François, MD ; Gagnon, Alain, MD ; Johnson, Jo-Ann, MD ; Wyatt, Philip, MD, PhD ; Allen, Victoria, MD ; Langlois, Sylvie, MD ; Blight, Claire, RN ; Chitayat, David, MD ; Farrell, Sandra A., MD ; Nelson, Tanya, PhD ; Nikkel, Sarah M., MD ; Skidmore, David, MD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-e289t-e3cd9192e7d399a023e165a6b3f0e02541149e03b0899e666f69041449a8682d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Amniocentesis - adverse effects</topic><topic>Female</topic><topic>Fetal Death - epidemiology</topic><topic>Fetal Death - etiology</topic><topic>genetic amniocentesis</topic><topic>Humans</topic><topic>miscarriage</topic><topic>Obstetrics and Gynecology</topic><topic>Pregnancy</topic><topic>Pregnancy Trimester, Second</topic><topic>prenatal screening</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wilson, R. Douglas, MD, FRCSC</creatorcontrib><creatorcontrib>Langlois, Sylvie, MD, FRCPC</creatorcontrib><creatorcontrib>Johnson, Jo-Ann, MD, FRCSC</creatorcontrib><creatorcontrib>Wilson, R. Douglas, MD</creatorcontrib><creatorcontrib>Desilets, Valerie, MD</creatorcontrib><creatorcontrib>Audibert, François, MD</creatorcontrib><creatorcontrib>Gagnon, Alain, MD</creatorcontrib><creatorcontrib>Johnson, Jo-Ann, MD</creatorcontrib><creatorcontrib>Wyatt, Philip, MD, PhD</creatorcontrib><creatorcontrib>Allen, Victoria, MD</creatorcontrib><creatorcontrib>Langlois, Sylvie, MD</creatorcontrib><creatorcontrib>Blight, Claire, RN</creatorcontrib><creatorcontrib>Chitayat, David, MD</creatorcontrib><creatorcontrib>Farrell, Sandra A., MD</creatorcontrib><creatorcontrib>Nelson, Tanya, PhD</creatorcontrib><creatorcontrib>Nikkel, Sarah M., MD</creatorcontrib><creatorcontrib>Skidmore, David, MD</creatorcontrib><creatorcontrib>CCMG PRENATAL DIAGNOSIS COMMITTEE</creatorcontrib><creatorcontrib>SOGC GENETICS COMMITTEE</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><jtitle>Journal of obstetrics and gynaecology Canada</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wilson, R. Douglas, MD, FRCSC</au><au>Langlois, Sylvie, MD, FRCPC</au><au>Johnson, Jo-Ann, MD, FRCSC</au><au>Wilson, R. Douglas, MD</au><au>Desilets, Valerie, MD</au><au>Audibert, François, MD</au><au>Gagnon, Alain, MD</au><au>Johnson, Jo-Ann, MD</au><au>Wyatt, Philip, MD, PhD</au><au>Allen, Victoria, MD</au><au>Langlois, Sylvie, MD</au><au>Blight, Claire, RN</au><au>Chitayat, David, MD</au><au>Farrell, Sandra A., MD</au><au>Nelson, Tanya, PhD</au><au>Nikkel, Sarah M., MD</au><au>Skidmore, David, MD</au><aucorp>CCMG PRENATAL DIAGNOSIS COMMITTEE</aucorp><aucorp>SOGC GENETICS COMMITTEE</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Mid-Trimester Amniocentesis Fetal Loss Rate</atitle><jtitle>Journal of obstetrics and gynaecology Canada</jtitle><addtitle>J Obstet Gynaecol Can</addtitle><date>2007-07-01</date><risdate>2007</risdate><volume>29</volume><issue>7</issue><spage>586</spage><epage>590</epage><pages>586-590</pages><issn>1701-2163</issn><abstract>Abstract Objective To determine the postprocedure loss rate for mid-trimester genetic amniocentesis. Outcome Reduction of benign biopsy rates. Benefits To provide better advice for women about the risks and benefits of mid-trimester genetic amniocentesis, and to ensure that women are given sufficient information/counselling to make a decision about screening. Summary Statement The risk of postprocedure loss is unique to the individual and is based on multiple variables.</abstract><cop>Netherlands</cop><pub>Elsevier Inc</pub><pmid>17623573</pmid><doi>10.1016/S1701-2163(16)32501-4</doi><tpages>5</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1701-2163 |
| ispartof | Journal of obstetrics and gynaecology Canada, 2007-07, Vol.29 (7), p.586-590 |
| issn | 1701-2163 |
| language | eng |
| recordid | cdi_pubmed_primary_17623573 |
| source | MEDLINE; Alma/SFX Local Collection; EZB Electronic Journals Library |
| subjects | Amniocentesis - adverse effects Female Fetal Death - epidemiology Fetal Death - etiology genetic amniocentesis Humans miscarriage Obstetrics and Gynecology Pregnancy Pregnancy Trimester, Second prenatal screening |
| title | Mid-Trimester Amniocentesis Fetal Loss Rate |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-07T15%3A15%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_elsev&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Mid-Trimester%20Amniocentesis%20Fetal%20Loss%20Rate&rft.jtitle=Journal%20of%20obstetrics%20and%20gynaecology%20Canada&rft.au=Wilson,%20R.%20Douglas,%20MD,%20FRCSC&rft.aucorp=CCMG%20PRENATAL%20DIAGNOSIS%20COMMITTEE&rft.date=2007-07-01&rft.volume=29&rft.issue=7&rft.spage=586&rft.epage=590&rft.pages=586-590&rft.issn=1701-2163&rft_id=info:doi/10.1016/S1701-2163(16)32501-4&rft_dat=%3Cpubmed_elsev%3E17623573%3C/pubmed_elsev%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/17623573&rft_els_id=1_s2_0_S1701216316325014&rfr_iscdi=true |